Cargando…
Biomarkers for Predicting Anti-Programmed Cell Death-1 Antibody Treatment Effects in Head and Neck Cancer
In recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC), survival outcomes are significantly better in patients who receive anti-programmed cell death-1 (PD-1) monoclonal antibody therapy than in those who receive standard therapy. However, there is no established biomarker that...
Autores principales: | Tanaka, Katsunori, Hirakawa, Hitoshi, Suzuki, Mikio, Higa, Teruyuki, Agena, Shinya, Hasegawa, Narumi, Kawakami, Junko, Toyama, Masatomo, Higa, Tomoyo, Kinjyo, Hidetoshi, Kise, Norimoto, Kondo, Shunsuke, Maeda, Hiroyuki, Ikegami, Taro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297315/ https://www.ncbi.nlm.nih.gov/pubmed/37366893 http://dx.doi.org/10.3390/curroncol30060410 |
Ejemplares similares
-
p16 Overexpression in Sinonasal Squamous Cell Carcinoma: Association with Human Papillomavirus and Prediction of Survival Outcomes
por: Hirakawa, Hitoshi, et al.
Publicado: (2023) -
Human Papillomavirus Infection and EGFR Exon 20 Insertions in Sinonasal Inverted Papilloma and Squamous Cell Carcinoma
por: Hirakawa, Hitoshi, et al.
Publicado: (2023) -
Development of Antibodies against HPV-6 and HPV-11 for the Study of Laryngeal Papilloma
por: Ikegami, Taro, et al.
Publicado: (2021) -
Coordinated Expression of HPV-6 Genes with Predominant E4 and E5 Expression in Laryngeal Papilloma
por: Ikegami, Taro, et al.
Publicado: (2021) -
Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma
por: Kondo, Shunsuke, et al.
Publicado: (2021)